Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Veteran Peter Chambré Joins Cancer Research UK

Executive Summary

Cancer Research UK has appointed Peter Chambré trustee. He is currently chair of various life sciences and healthcare companies including Immatics Biotechnologies and OneMed and chairs Cancer Research’s commercialization arm, Cancer Research Technology Ltd. (CRT). Chambré is also director of Spectris PLC and Imperial Innovations PLC and was previously CEO of Cambridge Antibody Technology PLC until its acquisition by AstraZeneca in 2006.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC096908

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel